Search results
Quality of Life After AVR
Author(s):
Meng He
,
Jinwei Zhang
,
Jianbo Yu
,
et al
Added:
5 months ago
Article
Author(s):
Ahmad Jabri
,
Anas Alameh
,
Gennaro Giustino
,
et al
Added:
1 year ago
Author(s):
Nicolas M Van Mieghem
Added:
1 year ago
TCT Conference 2024 - Safety and efficacy outcomes of transcatheter aortic valve replacement (TAVR) in addition to optimal heart failure therapy (OHFT) compared to OHFT alone in patients with heart failure and moderate aortic stenosis.Dr Nicolas M Van Mieghem (Erasmus University Medical Center, Rotterdam, NL) joins us onsite at TCT Conference to discuss the findings from TAVR UNLOAD (NCT02661451)…
View more
Author(s):
Nicolas M Van Mieghem
,
Joost Daemen
Added:
1 year ago
What’s hot at ACC.24?Join interventional experts, Prof Nicolas Van Mieghem and Dr Joost Daemen (Thoraxcenter, Erasmus MC, Rotterdam, NL) to learn more about this year’s key late-breaking and featured science trials that have the potential to shape practice and research.This preview episode of View from the Thoraxcenter offers a critical analysis of the most anticipated trials of ACC.24,…
View more
Kendra J Grubb
Job title: Surgical Director
Author
Gilbert Tang
Author
Elvin Kedhi
Job title: Interventional Cardiologist
Author
Robert Hebeler
Job title: Attending Surgeon
Author
Added:
2 years ago
Source:
Radcliffe Cardiology
Find out what's hot at TCT in this preview from Prof Nicolas Van Mieghem and Dr Joost Daemen
The Cardiovascular Research Foundation (CRF) has unveiled the late-breaking clinical trials scheduled for presentation at the 2023 Transcatheter Cardiovascular Therapeutics (TCT) annual meeting taking place from October 23 to 26 in San Francisco. TCT is renowned for showcasing groundbreaking research in…
View more
Carlos E Ruiz
Job title: Director of the Congenital and Structural Heart Disease
Author
